Surrey researchers Sign in
Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer (visualised by micro CT)
Conference presentation

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer (visualised by micro CT)

S Pandha, GR Simpson, A Horvath, RS Coffin, T Pencavel and K Harrington
BRITISH JOURNAL OF SURGERY, Vol.98, pp.52-53
Annual Meeting of the Society-of-Academic-and-Research-Surgery (Royal Coll Surgery, Dublin, IRELAND, 05/01/2011 - 06/01/2011)
01/04/2011

Abstract

Science & Technology Life Sciences & Biomedicine Surgery SURGERY
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290664500174&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

42 Record Views

Details

Usage Policy